Valuation Oxford Nanopore Technologies plc
Equities
ONT
GB00BP6S8Z30
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.80 GBX | -2.97% |
|
+3.96% | -5.92% |
| 04-20 | Roadside Real Estate CEO buys after Hoch purchase | AN |
| 04-15 | Cepheid and Oxford Nanopore Technologies Expand Partnership for Infectious Disease Research Collaboration | CI |
Company Valuation: Oxford Nanopore Technologies plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,726 | 2,034 | 1,788 | 1,230 | 1,169 | 1,169 | - |
| Change | - | -64.48% | -12.1% | -31.22% | -4.99% | 0% | - |
| Enterprise Value (EV) 1 | 5,263 | 1,712 | 1,560 | 937.5 | 1,026 | 962.6 | 1,014 |
| Change | - | -67.48% | -8.87% | -39.89% | 9.48% | 7.21% | 5.37% |
| P/E ratio | -30.3x | -22.4x | -11x | -8.05x | -8.5x | -10.7x | -16x |
| PBR | 8.15x | 2.93x | 2.7x | 1.97x | 2.66x | 3.28x | 4.07x |
| PEG | 0.3x | 0.4x | -0.2x | 0.5x | 1.51x | 0.4x | 0.5x |
| Capitalization / Revenue | 42.8x | 10.2x | 10.5x | 6.71x | 5.54x | 4.26x | 3.39x |
| EV / Revenue | 39.4x | 8.62x | 9.19x | 5.12x | 4.58x | 3.51x | 2.94x |
| EV / EBITDA | -91.2x | -21.8x | -14.9x | -8.07x | -11.8x | -17.5x | -162x |
| EV / EBIT | -63.5x | -15.5x | -10.6x | -5.88x | -7.54x | -8.93x | -15.5x |
| EV / FCF | -69.8x | -18.7x | -9.59x | -5.91x | -8.83x | -12.5x | -24.8x |
| FCF Yield | -1.43% | -5.35% | -10.4% | -16.9% | -11.3% | -7.98% | -4.03% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -0.23 | -0.11 | -0.19 | -0.16 | -0.151 | -0.1132 | -0.0754 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 133.7 | 198.6 | 169.7 | 183.2 | 223.9 | 274.1 | 345.1 |
| EBITDA 1 | -57.7 | -78.63 | -104.9 | -116.1 | -86.7 | -54.91 | -6.27 |
| EBIT 1 | -82.9 | -110.5 | -146.6 | -159.4 | -136.1 | -107.8 | -65.54 |
| Net income 1 | -167.6 | -91.02 | -154.5 | -146.2 | -145.2 | -109.6 | -75.87 |
| Net Debt 1 | -463 | -322.7 | -228.4 | -292.4 | -213.8 | -205.9 | -154.2 |
| Reference price 2 | 6.980 | 2.465 | 2.082 | 1.288 | 1.208 | 1.208 | 1.208 |
| Nbr of stocks (in thousands) | 820,404 | 825,255 | 858,887 | 954,914 | 967,364 | 967,364 | - |
| Announcement Date | 22/03/22 | 21/03/23 | 06/03/24 | 04/03/25 | 02/03/26 | - | - |
1GBP in Million2GBP
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.37x | 4.19x | -10.09x | -.--% | 1.63B | |
| 26.34x | 4.71x | 18.4x | 0.35% | 195B | |
| 52.56x | 13.22x | 30.86x | -.--% | 160B | |
| 30.93x | 5.76x | 17.98x | 0.75% | 138B | |
| 24.19x | 4.26x | 14.22x | -.--% | 88.46B | |
| 19.44x | 2.27x | 11.24x | 2.72% | 49.91B | |
| 27.55x | 6.18x | 19.79x | -.--% | 45.96B | |
| 23.41x | 4.79x | 16.61x | 0.84% | 34.5B | |
| 14.92x | 1.72x | 9.35x | 0.22% | 32.97B | |
| 29x | 5.77x | 18.24x | -.--% | 32.91B | |
| Average | 24.00x | 5.29x | 14.66x | 0.49% | 77.93B | |
| Weighted average by Cap. | 31.36x | 6.45x | 19.51x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- ONT Stock
- Valuation Oxford Nanopore Technologies plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition